Jennifer A Doherty
Overview
Explore the profile of Jennifer A Doherty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
5378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lawson-Michod K, Marks J, Collin L, Nix D, Davidson N, Huff C, et al.
Cancer Res
. 2025 Mar;
PMID: 40063699
Black individuals experience worse survival after a diagnosis of high-grade serous ovarian carcinoma (HGSC) than White individuals and are underrepresented in ovarian cancer research. To date, the understanding of the...
2.
Collin L, Cushing-Haugen K, Terry K, Goode E, Wu A, Harris H, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Feb;
PMID: 40009771
Background: Ovarian high-grade serous carcinomas (HGSC) comprise four distinct molecular subtypes based on mRNA expression patterns, with differential survival. Understanding risk factor associations is important to elucidate the etiology of...
3.
Lawson-Michod K, Johnson C, Barnard M, Davidson N, Collin L, Nix D, et al.
medRxiv
. 2025 Feb;
PMID: 39974072
Background: Approximately half of ovarian high-grade serous carcinomas (HGSC) have homologous recombination deficiency (HRD). However, HRD is not well-characterized in Black individuals. Objective: To characterize HGSC HRD by self-reported race...
4.
Nagle C, Ibiebele T, Na R, Bandera E, Cramer D, Doherty J, et al.
Am J Clin Nutr
. 2025 Feb;
PMID: 39921094
Background: Prognosis after a diagnosis of invasive epithelial ovarian cancer is poor. Some studies have suggested modifiable behaviors, like diet, are associated with survival but the evidence is inconsistent. Objectives:...
5.
Mongiovi J, Townsend M, Vitonis A, Harris H, Doherty J, Babic A, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Feb;
PMID: 39912719
Background: Parity and breastfeeding are associated with systemic changes in maternal inflammation and reduced risk of ovarian cancer, but little is known about their impact on the ovarian tumor immune...
6.
McCarty R, Trabert B, Kriebel D, Millar M, Birmann B, Grieshober L, et al.
Cancer Med
. 2024 Oct;
13(20):e70260.
PMID: 39444249
Background: Approximately one-third of US adults have a tattoo, and the prevalence is increasing. Tattooing can result in long-term exposure to carcinogens and inflammatory and immune responses. Methods: We examined...
7.
McCarty R, Trabert B, Millar M, Kriebel D, Grieshober L, Barnard M, et al.
Res Sq
. 2024 Sep;
PMID: 39257981
Background: Little is known about current characteristics of individuals with tattoos. We quantified the prevalence of tattooing and associations of demographic, health, and risk-behavior factors with tattooing. Methods: We computed...
8.
Mukand N, Chirikova E, Lichtensztajn D, Negoita S, Aboushwareb T, Bennett J, et al.
Cancer
. 2024 Aug;
130(24):4298-4305.
PMID: 39158464
Background: The Oncotype DX Genomic Prostate Score (ODX-GPS) is a gene expression assay that predicts disease aggressiveness. The objective of this study was to identify sociodemographic and regional factors associated...
9.
Petkov V, Byun J, Ward K, Schussler N, Archer N, Bentler S, et al.
J Natl Cancer Inst Monogr
. 2024 Aug;
2024(65):168-179.
PMID: 39102888
Background: Precision medicine has become a mainstay of cancer care in recent years. The National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program has been an authoritative source...
10.
Sanchez P, Van Dyke A, Petkov V, Yuan Y, Bonds S, Valenzuela C, et al.
J Natl Cancer Inst Monogr
. 2024 Aug;
2024(65):180-190.
PMID: 39102878
Background: The Surveillance, Epidemiology, and End Results (SEER) Program with the National Cancer Institute tested whether population-based cancer registries can serve as honest brokers to acquire tissue and data in...